Automated Screening Platforms in BSL2+ (Opera Phenix Plus, Operetta CLS, Ensight, Envision) / BSL3 (Operetta CLS, Nivo) to support the drug discovery pipeline and therapeutics. Any assay model (phenotypic, target, 3D) can be run against our libraries for drug repositioning, new chemical entities, target ID, and MOA assessment.
Advanced Liquid Handlers to support any process including Echo Acoustic Dispenser, Biomek, and Janus.

Our objective is to create customized, cost-effective tool and instrument utilizing readily available technology to address scientific needs. Once you reach out to us, we will arrange a teleconference meeting to delve into the project. Subsequently, we will engage in an iterative interaction, progressing from the initial design concept to the actual creation of the tool or instrument. This comprehensive approach may span several months to ensure a successful and satisfying outcome

Our platform facilitates the exploration of protein-protein interactions (PPI) within living cells, utilizing a diverse range of high-throughput methods. We harness the power of the Bioluminescence Resonance Energy Transfer (BRET) technique for the precise quantification of proteins of interest, including, for example, pathogen/host protein pairs. What distinguishes our method is its capability to continuously monitor these interactions in real time within living cells for extended durations. This versatile approach supports a wide array of applications, including PPI validation, time-lapse PPI cell quantification, assessment of affinity in mutant PPI pairs, PPI competition studies, and screening for PPI modulators in drug discovery.